Signature,intervalBetweenDiagnosis
Other,cutaneousManifestationsOfBreastCancer
Other,lungMetastasesFromBreastCancerPresented
Other,twoUncommonCasesOfDelayedBreastCancerRelapses
Considerable,significantIncrease
Focus,experimentalStudyOfCryo-stabilityOfCancerCells
Care,healthcareCost
Other,affected
Distinct,differentPatientRaces
Cohort,itsPoorPrognosis
Trastuzumab,trastuzumabTherapyForBreastCancer
Axis,combination
Other,managementOfTumour-relatedSymptoms
Lymphedema,lymphedemaPatients
Proportion,prognosticSignificanceOfNeutrophil-to-lymphocyteRatioInPatientsWithBreastCancer
Finding,tumorGrowthInExperimentalModels
Hazard,increasedRiskOfMortality/relapse
16,13PercecntOfDeaths
Other,shallow-CNN
Finding,tumorGrowth
Accumulation,lowerInEasternThanNorthern/centralEurope
Other,oneRegionAnother
Other,breast
Cell,canStarted
Spread,breastCancerCellInvasion
Other,extensiveMolecular
16,50
Targets,novelTherapeuticTargetsFor
Subgroup,onlySubgroupWithProgesteroneReceptor
Personalized,mustIndividualized
Other,usuallyAssociated
Entry,er-dependentTranscriptionalActivationViaTransactivationFunction1
Other,accessToReceptorAnalysesInCytosolAtDiagnosis
Evolve,stratifyingForAge
Adulthood,195Years
Other,nslnMetastasis
Other,commonMalignantDisease
Other,treatmentTherapy
Other,significanceLevel
Other,uncommon
Other,CTIBL
Intensity,qualityEvidence
Signature,response
Other,visits
Distinct,differentBreastCancerMolecularSubtypes
Other,inMultivariateModelsRelatedToPerformanceStatus
Platform,copyright
Mood,surgicalOptionsIncludingPreservationOfNippleAreolaComplex
Benchmark,potentialTarget
Required,required
Other,results
Intensity,emergingPublicHealthProblemInLowCountries
Other,properAccessToDiagnosis
Testing,testing
Bromide,periodOfObservation
Caregiver,veryRareCaseOfTraumaticBreastNeuroma
Distinct,mayDistinctEntity
Interference,assessment
Other,novelInsightsIntoPotentialMechanismsAssociatedWithBreastCancerPathogenesis
Cohort,youngWomenWithInvasiveLobularCarcinoma
Actual,currentCancerResearch
Other,controversial
Subtypes,differentiationBetweenBreastCancerInVariousSubtypesOfBreastCancer
Spouse,mutationalStatusBesidesFamilyHistory
Other,C1
Other,Ontario
Testing,invasiveDiseaseretrospectiveAnalysisOf219Cases
Other,mayIndicativeOfBenignLesion
Other,rates
Mechanism,termsOfMechanism
Actual,currentResults
Other,those
Other,real-time
Third-line,capecitabineRegimenAsThird-lineTreatmentForAdvancedTriple-negativeBreastCancer
Other,independent
Restoration,riskOfDevelopmentOfGliomas
Mood,haveAssociatedWithNippleAreolaComplexInvolvementInPatientsWithBreastCancer
Other,currentlyInsufficient
Hazard,outcomeInLymphedemaPatients
Other,pathogenesisOfBreastCancer
Other,respectivelyFound
Third-line,treatedWithCapecitabineMonotherapyAsThird-lineTherapy
Bromide,referenceForClinicians
Restoration,neededAcrossCareContinuumEspeciallyInLow-resourceSettings
Sensitive,highlySensitiveNano-biosensor
Evolve,evolve
Spouse,familyImpact
Other,advantages
Cell,canHeavilyInfluenced
Neoadjuvant,administrationOfNeoadjuvant
Exposure,nomogram
Advantage,interest
Other,delaysinTreatment
Cell,canCategorized
Necessity,inConclusionStillNecessaryForAdoptionOfCtnAsRoutineClinicalBiomarkerInPatientsWithBreastCancer
Hazard,risk
Other,bronchoalveolarCarcinomaUnrelatedToKnownMetastaticBreastCancer
Switched,howeverSwitched
Nucleus,posteriorFossaOfBrain
BRCA1,soFarHasMainlyAssociatedWithMutationsInBrca1
Cell-killing,cell-killingEffectInTriple-negativeSubtypeMda-mb-231Cells
Other,ultrasound
Caregiver,mostPervasiveTypeOfCancerAmongWomen
Other,defectStudies
Other,symptomaticWomen
Japanese,Japanese
Other,ICER
Discovery,moreResearchLight
Other,improved
Finding,identificationOfPredictiveBiomarkersForSelectionOfOptimalTreatment
Other,researchers
PCOS,32620MatchedPatientsWithoutPcos
Other,detected
Focus,amongThemNewlyIdentifiedInStudy
Complex,acid
Focus,multicenterStudy
Description,resultCompatibleWithMetastasisToOrbit
Reduced,small
Water,field
Output,capacity
Other,clinicopathologicalCriteria
Discovery,detectionOfMicrocalcificationInMammograms
Lung/bronchus,lung/bronchusMalignancies
Other,calculated
Satisfied,moreSatisfiedWithTheirCosmeticResultsThanThose
Proliferation,molecularPathwaysInvolvedInPathogenesisOfProliferation
Subtypes,canCategorizedIntoSubtypesOfLuminalA
Other,breastCancerPatientsSerum
Other,diagnosisOfEstrogenReceptor
Other,alteredInHumanBreastCarcinoma
Components,specificCancerCell-relatedComponents
Pleurodesis,pleurodesisForMalignantPleuralEffusion
Anemia,Anemia
Ecchymosis,dscam-as1Expression
Susceptibility,proactiveManagementOfPsychologicalHealth
Craniotomy,surgicalExcisionWithRadiation
Robust,strongAssociationBetweenRs5743810AgainstRiskInSaudiArabianWomen
Other,betterResults
Signature,haveDescribedInResponseToNeoadjuvantChemotherapyParticularlyInAssociationWithHerceptinTreatment
Other,higher
Intensity,high
Other,improvedDiagnosis
Intensity,lowDiagnosticSensitivityForWomenWithDenseBreasts
Subset,thanCapecitabineGroup
Numerous,manyResearchers
Number,correspondingCohort
Conflict,typeOfCollisionTumor
Focus,lymphNodeMetastasisInPatientsWithBreastCancer
Other,incidenceAmongMalignancies
Discovery,detectionRateOfMutationsHigherThanThatDescribedInLiterature
Other,oneRegion
Result,threeCtcsIsolatedFromOnePatient
16,120BreastCancerPatients
Other,464Percecnt
Other,achieved
Other,importantInsightsIntoDiagnosisOfPatientsWithDisease
Distinct,differentPhenotypes
Other,avoidance
Contribution,fearOfPartnerLoss
Interference,evenLessFrequentComplication
Other,likelihood
Other,casesWithoutMetastasisOnDiagnosticImaging
Other,presence
Apatinib,comparedBetween2GroupstheApatinib
Restoration,developmentOfSubsequentLung/bronchusCancer
Other,patterns
Subgroup,importantlyCouldPotentialDiagnosticBiomarkerInEthnicPopulation
Susceptibility,changesToIntimateIssuesIncludingSexualHealth
Ecchymosis,proteinExpressionOfNf-krab-p65
Other,drastic
Other,moreDirectional
Isolation,kaplan-meierRegressionMethods
Other,thereforeApplied
Cell,canIncluded
Other,increasedMalignantPotential
Other,tnmStage
Other,adjacentNon-tumorousTissues
Survival,significantlyCorrelatedWithOverallSurvival
16,only20Percecnt
Other,spectrum
Allele,dominantArms
Strategy,multimodalityTreatmentStrategy
Other,adherenceToRecommendationWith95PercecntConfidenceIntervals
Intensity,influenceOfSleepQualityOnPmInPatientsTreatedWithHt
Restoration,clinicalCare
Personalized,personalizedFollow-upSchemes
Heterogeneity,intratumoralHeterogeneityOfKindOfTumor
Mechanism,potentialMechanismForFoxc1-inducedMetastasis
Formed,shaped
Alpha,comorbiditiesThanSPatients
Other,importantTumor-promotingCells
Intensity,associatedWithPfsAlthoughAtExtent
Provider,riskFactorForLung/bronchusCancer
Other,explored
Basis,whenGiven
Other,adherence
Other,patientsWithBreastCancerReceivingWithAnthracyclines
Other,thatOfOtherCountries
Caregiver,roleOfPrimaryCaregiver
Danger,commonCauseOfMorbidity
Other,gynaecologicalMetastases
Other,0.003
Care,extensiveAttentionOfResearchers
Provider,patientsWithHumanEpidermalGrowthFactorReceptor2
Sensitive,classified
Elusive,stillDifficult
Other,negativeMargins
Considerable,significant
Other,functions
Actual,currentUsersOfLongerDuration
Intensity,qualityOfLifeOfPatients'Spouses
Restoration,structureChanges
Other,widelyExpressed
Cell,canIncludedInDifferentialDiagnosisOfMasses
Distinct,differentPhotosensitizerForPhotodynamicTherapy
Other,approaches
Chosen,fewPercentOfWomen
Mood,danger
Exposure,itsPerformance
Postmenopausal,relativeThoseOfPostmenopausalPatients
Signatures,signatures
Other,diagnosisOfPatientsWithBreastCancer
Distinct,differentFunctionRegions
Allele,tumorSuppressorFunctionOfP53InPathogenesisOfBreastCancer
Advantage,widespreadInterest
Other,described
Hazard,breastCancerRisk
Other,.021
Glycosylation,glycosylation
Other,serumSamplesFromCancerPatients
Areola,sideEffectsOfBreastCancerTherapiesIncludingHotFlushes
Other,876PercecntRespectively
Utilized,mayUsed
Revealed,additionallyRevealed
Survival,survivalDifferences
Circulating,expressionOf6CirculatingMirnasInOperablePatients
Other,positive
16,40Percecnt
Young,femalePatientsWithAd
Other,compared
Other,13-hDailyOvernightFast
Advantage,advantage
Mood,thusInRecentYearsDemand
Other,thusAimed
Entry,initiationOfPromptTherapy
Other,largelyConsistent
Other,severalObjectives
Distance,boneDensity
Other,diagnosisOfSulinicalPrimaryCarcinomas
Other,surgery
Hypomethylated,hypomethylated
Other,pregnancyFrom1959To1966
Distinct,clinicalVariablesAmongDifferentGroups
Robust,strong
Adulthood,breastCancerYoungerThan45Years
Intensity,bodyMassIndex
Other,pairedUntreatedPrimaryTumor
Intensity,lowRiskLesions
Other,differentiallyExpressedInBreastCancerCells
Other,onlyWomen
Alpha,S
Bromide,patientSelectionForNon-pcosReferenceCohort
Testing,lastFollow-upTime
Ecchymosis,expressionLevel
Other,haveClarified
Other,influences
Other,alsoAssessed
Other,differentmethodsOfSelf-treatment
SE,SE
Entry,trastuzumabInitiation
Other,stable
Reduced,significantlyDecreased
Other,aberrantlyExpressed
Other,outcomesOfEstrogenReceptorPositive
Other,consequentlyHaveDeveloped
Evolve,evolveTowardLessSurgery
Discovery,researchLight
Necessity,necessary
Evolve,age
Other,dissection
Other,electricalDouble-layerCapacitors
Purpose,associationBetweenPost-diagnosisUseOfLow-doseAspirin
Other,correlated
Other,singleMetastaticSite
Other,an
Delays,higherRisksOfTreatmentDelays
Distinct,hasAlreadyAssociatedWithDifferentCancersNon-hodgkin'sLymphoma
Testing,riskFactorsOfLviByMultivariateAnalysis
Other,able
Adult,multiyearCollaborationLedByUnionForInternationalCancerControl
T2,irregularHyperintenseLesionInT2InLeftParietalRegion
Benchmark,baselineBpeLevels
Other,humanLife
Symptom,symptomBurden
Locoregional,patientsWithLocoregionalInSouthernPortuguese
16,secondDecadeAfterDiagnosis
Basis,given
Purpose,roleOfSupportOfferedByVirtualCommunitiesToBreastCancerPatients
European,9EuropeanCountries
Other,992Percecnt
Other,times
Other,howeverMoreDrastic
Other,images
Hazard,riskFactors
Other,recognized
Odds,prevalenceOfobesityOf277Percecnt
Purpose,broadUseToPatients
Genes,genesInvolved
Benchmark,patientsWithReducedBaselineLvef
Other,proposed
Other,proposedForBreastTumorGrading
Township,thenLinkedToTownshipFemaleBreastCancerIncidenceRateIn2000s
Other,howeverNon-ideal
Testing,primaryPurposeOfPeriodicMammogramsInScreeningProgramsIs
Other,mistaken
Ecchymosis,relationshipBetweenStromalExpressionOfPodoplaninInInvasiveBreastCarcinoma
Provider,independentPrognosticFactor
Cohort,ctcsFromPeripheralBlood
Other,indispensable
Number,number
Actual,mostEffectiveTechniqueused
Restoration,goodDiagnosticAbility
Intensity,dramaticallyIncreasedAmount
Subset,group
Adult,february2012InNargisDuttMemorialCancerHospital
Odds,correlationsBetweenOdds
Adulthood,adulthood
Utilized,mostCommonAgentsUsedInBreastCancerTreatment
Other,potential
Contribution,urgentlyAdvanceImplementation
Other,0.007
Other,NMA
Mimics,needForAwarenessOfMimicsOfBoneMetastasis
Susceptibility,changesInHealthBehavioursAfterBreastCancerDiagnosis
Other,single-cellWhole-exomeSequencing
Cell,canClassified
Other,alternativeToFrozenSections
Other,reported
Provider,factor
Other,real-worldSetting
Restoration,theirCare
Other,descriptive
Contribution,bestStandardTreatmentRegimenAvailable
Other,whenonlyAnalyzed
Values,cutoffValues
Other,diagnosis
Conflict,strongContrastWithImagingModalities
Global,womenWorldwide
Other,her2/hrTripleNegativeTnmStages
Other,underutilized
VAP-1,vap-1ImmunohistochemicalStaining
Other,additionallyCorrelated
Danger,mostProminentCause
Discovery,detectionOfBreastCancerInWomen
Other,promising
Other,diagnosisOfCancer
Other,recentlyDiagnosedBreastCancer
Therapy-related,therapy-relatedConditionsDuringBreastCancerSurvivorship
Spouse,caseOf68-year-oldCaucasianFemaleWithFamilyHistoryOfCancer
Restoration,megakaryocyteMarker
Subset,preliminaryGroupOfCtibl
Binding,supportVectorMachine
Intensity,highMortalityRateForFemales
Finding,growthOfFbxo22-depletedEr-positiveBreastCancers
HER2,phForHer2AgainstHer2-overexpressedBreastCancer
Other,performed
Interference,chronicDebilitatingLifelongComplication
Subsequent,subsequentMalignancies
Considerable,significantChallenge
Young,193FemaleParticipants
Other,clinicalPractice
Hazard,associatedWithBreastCancerRisk
Number,increaseWithNumberOfSprays
Other,imagingInvestigations
Other,38Months
Other,2009-13
Restoration,usualCare
Desirable,desirable
Learning,termsOfClassification
Genes,highlyPenetrantGenes
Cell,canEasilyExtended
Considerable,largeCells
Other,spindleCells
Other,assessedPreoperatively
Testing,microscopicTestingOfHematoxylin
Mood,commonEndocrineDisorder
Global,mostPrevalentMalignancyAmongWomenAroundWorldAreDiagnosedYear
Mimics,twoCasesOfMimicsOfBoneMetastasis
Subgroup,generalBreastCancerPopulation
Other,potentialImportanceAsModelsForHumanBreastCancer
Other,3-timeAssessments
Other,rare
Other,tumorImaging
Other,undiagnosed
Other,likely
Other,occurrenceOfBreastCarcinoma
Output,additionalIndicator
Ecchymosis,expressionInBreastCancer
Finding,thereforeHasAppliedToEarlyIdentification
Other,CXCR4
Other,normalSamples
Strategy,potentialTreatmentStrategy
Factors,factors
Testing,detectedThroughScreeningThroughSigns
Other,theirParticularity
Hazard,increasedRiskOfEndometrialCancer
Intensity,highVolumeAcademicCenters
Cell,cancer-relatedEventsIncludingTumorCellMigration
Other,Porto
Manufactured,manufactured
Osteopontin,osteopontinPeptide
Other,inBreastTumorsKnownAsBreastCscs
Other,clinico-epidemiologicalFeaturesOfBreastCancer
16,16PrimaryBreastCancers
Other,magneticResonanceImaging
Actual,20PercecntIncreasedRiskOfBreastCancerAmongCurrentHormonalContraceptionUsers
Other,twoGroups
Delays,withandControllingForTreatmentDelays
Neuromas,only35CasesOfTraumaticBreastNeuromas
Other,heterogeneous
Other,breastCancerIncidence
Paraneoplastic,likelyParaneoplastic
Other,minimal
Other,importantProblem
Intensity,qualityOfLife
Hypomethylated,moreEasilyHypomethylated
Other,expected
Other,unmetPsychosocialNeeds
Evolve,significantlyYoungerAge
Other,mostCountries
Other,disseminatedDisease
Pure,moreAggressiveBiologicalNatureThanPureDcis
Other,hasPut
Switched,switched
Focus,mammaryMetastasisFromCarcinomaOfOvarianOrigin
Percent,percent
Utilized,used
Adulthood,recentYears
Allele,tumorSuppressorGene
Capillaries,bareCapillaries
Base,advancedBreastCancerBearingMutationsInGenesInvolvedInPi3k/ark/mtorSignalingPathway
Alpha,initialTreatmentAfterWhich
Other,YS
Reduced,significantlyReduced
PCOS,effectsOfPcosOnRisksOfGynecologicCancer
Township,township
Other,thenAdded
16,23Studies
Other,synonymous
Distance,characteristicsInsideTumors
Other,ribonucleotideReductaseM2
Other,year
Other,furthermoreSignificantlyMoreLikely
Mastectomies,bilateralTotalMastectomies
Danger,documentedAsImportantTumor-promotingAgentForSeveralHumanCarcinomasIncludingBreastCancer
Restoration,perceptionOfQualityOfCareProvidedByCancerCareNetworkForEarlyDetectionOfBreastCancer
Other,6Months
CTC,CTC
Provider,secretionOfTumorNecrosisFactor
Distinct,theirRelatedMarkersAtDifferentPointsOfChemotherapyRegimensInMetastaticBreastCancer
Restoration,rolePlayedByPdgfFamilyMembersInNormalDevelopmentOfBreastTissueDespiteItsPotentPro-lymphangiogenicEffects
Decrease,inTotalMatchedToCasesOnBirthYear
Isolation,penalizedLogisticRegression
Infrared,infraredFluorescentImagingInTripleNegativeInVitro
Other,505Percecnt
Other,designed
Actual,effectiveDiagnosisOfBreastCancer
Proliferation,proliferationOfCells
Focused,hasFocusedOnTumourCellsPrimarily
Other,two-thirdsOfBreastCancerCases
Other,attempted
Other,highestIncidenceAmongMalignanciesDiagnosedInWomen
Other,iU22
Other,level
16,30DoublingTimesNecessary
Township,shanxiProvinceOfChina
Platinum,itsMinimalSilverIonReleaseProfiles
Spouse,familyHistoryOfDisease
Interval,period
Other,effectsOfTreatment
Other,significantlyHigher
Actual,effective
Other,divided
Distinct,panelOfCellLinesWithDifferentPhenotypes
Distinct,willDifferent
Other,768PercecntSamplesWithOverexpressionIn76Cases
Other,their
Restoration,crucialImpactOnDevelopmentOfBreastCancer
Ecchymosis,expressionOfMir-511InBreastCancer
Global,globalHealth
Positivity,receiverOperatingCharacteristic
Other,18.791
Other,haveDeveloped
Other,haveObserved
Other,regulated
Other,knownHeterogeneousDisease
Distinct,effectivenessOfDifferentNpatsOnQolInPatientsWithBreastCancer
Trastuzumab,trastuzumabTherapy
Other,pCR
Other,clinicalSetting
Other,percecntRelapsedTissues
Other,sometimesMistaken
Other,administered
Other,chances
Other,significance
Other,treatmentMoreAccessibleToBreastCancerPatients
Discovery,determinationOfUnderlyingBiologyWithinTumors
Other,appropriateDiagnosisOfBreastCancer
Interference,interventionArm
Reduced,decreasedRiskOfBreastCancerInFemaleAdPatients
Prior,promisingShort-termStrategiesPriorToTreatmentAdministration
Consensus-based,consensus-based
Susceptibility,collectedFromElectronicHealthRecord
Other,MP
Intensity,higherProportion
Other,MortalityRates
Other,imaging
Other,mostInvasiveDisease
Intensity,proportion
Other,postponementVisiting
Coefficient,R
Restoration,developmentOfEffectiveDrugsForTreatmentOfHormone-dependentBreastCancer
PCDH10,methylationStatusOfPcdh10InBreastCancerTissues
Testing,byWhichObservedInNondestructiveWayThroughThermalAnalysis
Other,suggested
Other,high-resolutionImages
Output,indicator
WHI,WHI
Other,preoperativeCytologicalDiagnosisOfBreastCancerMetastasesInRegionalLymphNodesIn84Patients
Other,time
Conflict,difference
Discovery,timeIntervalsFromFirstDetectionToDiagnosis
Testing,pathologyForFurtherFollow-up
Other,imagingModalities
Description,publicHealthChallenge
Other,relevant
Other,relationship
Adult,activeNon-participants
Pathologically,firstPatientsWithPathologicallyTumor-freeNodes
Other,properties
Conflict,cancerDeathAmongWomenWorldwide
Phenotype,roleOfImage-basedTextureFeaturesAsNoninvasivePrognosticBiomarkers
Other,immune-mediatedCancer-associatedDisorders
Other,examined
Actual,comparisonOfPredictedIncidenceOfBreastCancerWithActualIncidenceInPopulation-basedStudies
Other,905Percecnt
Greater,greater
Other,Israel
Hazard,worseOutcome
Other,haveProducedInLaboratories
Mood,complexDueToPotentialFoetalRisksInSettingOfMaternalTreatment
Number,presentedWorkForFeatureExtraction
Susceptibility,healthExpectancyOfItspopulation
Other,normalTissues
HER2,achievedForHer2Status
Other,overexpressed
Postmenopausal,mainlyPostmenopausalWomen
Nonparticipation,resistanceToMultipleTypesOfTreatmentInBreastCancerModels
Other,support
Other,5CmLess
Subset,after6Months'TherapySignificantlyHigherIn3rdTertiaryGroup
1-2,breastCancerPatientsWith1-2PositiveSlnspatientsWithBreastCancer
Other,workflowConsistingOfImmunoaffinityPurification
Other,demonstrate
Hazard,highlyDiverseGroupOfMalignantNeoplasiaWithPoorOutcome
Intensity,quality
Robust,robustTechnology
Other,available
Mood,rangingFromDiagnosisPhaseToControlOfDisease
Other,higherRatesOfMisdiagnosisForBreastCancer
Collision,greatClinicalImpactForTumorDiagnosis
Food,patientEducationIdentification/reportingOfSideEffects
Accumulation,surveillanceData
Other,autonomyOfPatients
Restoration,care
Other,canineTumours
Issues,issuesRelatedToTherapeuticSequencingInLocalTherapyOfBreastCancer
Other,benignBreastLesions
Other,options
Other,themselves
Cell,canImportant
Other,oftenRelated
Other,established
Other,imperative
Other,FT
CEDM,49CedmCasesCollectedFromMayoClinic
Other,thoughtfulMultidisciplinaryPlanning
Symptom,effectOfDscam-as1
Susceptibility,improvementInClassificationOfMalignantLesions
Other,haveReportedMainlyAfterMastectomy
Lung/bronchus,incidenceFactorsOfSubsequentLung/bronchusPrimaries
Other,SRC
Other,earlyCancerDiagnosis
Other,excision/lumpectomy
Other,team
Other,therapeuticEffectsInBreastCancer
Testing,comparisonToCa15-3
Filter,handheldProbeCapable
Other,offered
Other,imagery
Strategy,policyActions
Discovery,multiplexedAssayForDetectionOfAutoantibodiesInCanineTumours
Resistance,greatPotentialOfClinicalApplication
Township,prognosisOfPatientsWithMaleBreastCancerInShanxiProvinceOfChinaFrom2007To2016
Other,1
Purpose,willUsedAsReferences
Other,tool
Targets,targets
Other,bilateralSalpingo-oophorectomy
Other,0.46
Users,users
Other,moreRecentlyHaveDeveloped
Other,mostFrequentlyOccurringCancer
KDM4B,KDM4B
Fertility,flowCytometry
Testing,moreIntensiveFollow-up
Entry,subsequentCancerCounselingOfFemaleSurvivors
Conflict,activityOfCellProliferationInBreastCancerCells
Other,hospitalFromJanuary2016ToFebruary2017
Reduced,decreased
Intensity,suchLowIncidence
Testing,medicalDiagnosisOfBreastCancer
Benchmark,significantlyHigherBaselineBpeLevelsThanPostmenopausalWomen
Other,grade
Other,731Percecnt
16,panelOf25GenesInvolvedInMechanismsOfTargetedTreatmentResistanceIn16PrimaryBreastCancersDevelopedDuringTreatment
Other,evaluated
Other,termsOfKyotoEncyclopediaOfGenes
Quantification,quantification
Other,added
Strategy,mightPromisingTherapeuticStrategyForHormone-therapyRefractoryEr
Other,her2-positiveInvasiveDuctalCarcinoma
Inverse,reverseTranscriptionQuantitativePolymeraseChainReaction
Other,relationshipBetweenNlr
Considerable,statisticallySignificantValuesAt4Cells/7MlBlood
Nonparticipation,tamoxifenResistance
Utilized,nowAlsoWidelyUsed
Discovery,detectionRate
Predominant,mostPrevalentType
Other,couldPotentialBiomarker
Technique,inexpensiveTechnique
Other,increased
Network,faSignalingNetwork
16,10Percecnt
Other,haveDiscovered
Bromide,breastCancerPatientsWithParticularReferenceToOverallSurvivalAndrecurrenceFreeSurvivalAmongBreastCancerPatients
Positivity,diagnosticAccuracy
Other,observations
Adulthood,1YearTo5Years
Spouse,femaleSibling
Subset,thatInNon-pcrGroup
Other,moreAdvancedStagingAtDiagnosisInWomen
Other,rituximab
Lung/bronchus,subsequentLung/bronchusMalignancies
Focus,includedInStudy
Resistance,thusWouldCrucialForApplicationOfPreventiveStrategies
Other,historyOfBreastCancer
Provider,prognosticFactorIndependentOfOtherClinicalVariables
Chosen,chosen
HER2,patientsWithHer2
Restoration,standardOfCareAsFirst-lineTreatmentOfPatientsWithHer2-positiveAEvenInReal-worldSetting
Other,foxc1-knockdownBt549Cells
Other,third
Other,hasFound
Other,immunohistochemicalTests
Exposure,highestPerformance
Focus,rightMastectomyWithSentinelLymphNodeBiopsy
Biopsy,openBiopsyOfNodularityAttachedToPectoralMuscleFascia
Adulthood,62Years
Satisfied,satisfied
Other,over-represented
Other,inFluorescenceImaging
Intensity,amount
Interference,inCaseSecondaryToProximalBronchialObstruction
Benchmark,exon32OfMammalianTargetOfRapamycin
MiR-204-5p,miR-204-5p
Benchmark,potentialTherapeuticTarget
Genes,severalOtherGenes
Other,relation
Intensity,higherProportionOfPatientsWithLymphedema
Restoration,relativelyGoodPrognosisWith5YearOverallSurvivalOf88Percecnt
Platinum,haveBackboneOfSuchEnormousStridesOfAu
Other,downregulated
Distinct,cnvsOfDifferentCancers
Intensity,improvedQualityOfLife
Testing,effectivenessOfNationalScreeningProgrammes
Focus,highDetectionRateOfSentinelLymphNodeComparableWithRiMethod
Type,description
Other,created
Other,Stem-likeCells
Caregiver,glycosylationOfMembraneTypeMr
Binding,binding
Other,haMoietyForPdt
Other,modeled
Purpose,function
Other,enhancedPossibility
Robust,strongIndependentPrognosticFactor
Other,clinicalBreastCancerTrials
Other,sensitivity
Restoration,newOpportunitiesForDevelopmentOfNovelTherapeuticStrategies
Restoration,cancerCareNetwork
Binding,mir-193b-3pBinding
Other,identifiablePcrResults
Other,shouldProceede
Utilized,inPaperUsed
Other,betterPrognosis
Evolve,inConclusionMajorHereditaryBreastCancerGenesIrrespectiveOfAgeAtDiagnosisInJapaneseWomen
16,womenWithMore70PercecntOfPatientsTreatedWithHormonalTherapy
Cohort,poor
Intensity,asInCaseShouldAlwaysKeptInMindSpeciallyInHighVolumeCenters
Testing,histopathologicalExamination
Fertility,potentialImpactOnFertilityAfterTreatment
Other,shown
Platform,area
Other,1973To2014
Learning,ronInternalization
Other,fiveGroups
Mood,mood
Other,locallyAdvancedBreastCancer
Other,howeverKnown
Other,oneRandomlyAssignedToAxillaryDissection
Focus,case-controlAssociationStudyForVariantsInCodingRegionsOf11HereditaryBreastCancerGenesIn7051UnselectedBreastCancerPatientsOfJapaneseAncestry
Other,stronglyPositive
Other,1Year
Other,thriceHigher
16,couldIndependentPrognosticBiomarkerForMPatients'Outcomes
Other,0.32
Other,shouldKept
Cohort,theirExperiencesLivingWithSister
Network,bayesianNetworkMeta-analysis
Design,formulation
Restoration,clinicalCharacteristicsOfCareOfBreastCancerPatients
Other,tumorigenesisOfBreastCancer
Other,up-regulated
Other,better
Other,consultations
Other,mostCommonCancerInWomen
Mood,60ControlPatients
Ecchymosis,expression
Signatures,efficientSignaturesForClinicalDiagnosis
Testing,follow-up
Other,synthesized
Interference,complication
Mood,complex
Distinct,differentGeneticProfile
Binding,bindingToBreastCancerCellsInVitro
Global,17MillionPeopleWorldwide
Description,zebrafishTumorModel
Other,henceMainlyBased
Other,Cells
Other,131Percecnt
Accumulation,abstractDataOnTheirClinicalCharacteristics
Other,tested
Strategy,revisionsOfAjccBreastCancerStagingSystem
Focus,resultsOfStudy
Cell,cellMigration
Other,serious
Other,mda-mb-231Cells
Other,forWomenWithBreastCancerMayMoreFeasible
Other,treatmentOfBreastCancer
Township,accurateViewOfStateOfMetastasesToAxillaryLymphNodes
Other,weak
Factors,protectiveFactors
Numerous,stillSeriousHealthProblemIn21stCenturySubjectToManyResearch
Contribution,inCaseReportTypicalOfAdvance
Other,understood
Mood,moodOfLife
Other,variousEnvironments
Susceptibility,whenIntegratedWithinCountry/region'sHealthPlan
Subjective,existingEvidenceOnPersonalGoal-settingAmongWomenWithBreastCancerDiagnosis
Purpose,time-varyingPost-diagnosisLow-doseAspirinUse
Considerable,recognizedAsCtcIn1Of15HealthyBloodSamples
Elusive,themVeryDifficult
Conflict,toEndDevelopedWithDrugToAntibodyRatioOf329
Other,uniqueProperties
Genes,breastCancerGenes
Other,oestrogenReceptorPositiveIn58PercecntOfCasesPositiveIn62Percecnt
Other,hasMadeInMolecularSubtypingOfBreastCancer
Other,lesion
Alpha,dataOfN=
Other,shouldElaborated
16,f-boxProtein22
Restoration,standardOfCareForBreastCancer
MiRNA-21,eventHybridizationOfMirna-21Biomarker
Will,understandingOfEmergingConceptsOfTumorBiology
Other,processes
Other,them
Cell,cellProliferation
Other,confirmed
Ecchymosis,rrm2Expression
Exposure,performanceEvaluation
Utilized,recentlyHaveUsedAsBiomarkers
Other,stratification
Type,localizedDescriptionOfBreastCancer
Other,critical
Distinct,differentSubtype
Other,objectives
Focus,associationStudy
Other,scrutinized
Strategy,treatmentStrategy
Mood,control
Desirable,moreDesirable
Amplification,addition
Other,diverse
Other,commonMedications
Other,uptake
Other,lessLikely
Other,obtained
Cohort,moreoverPoor
Other,4.71
Cell,canEffectivelyTreatedByEndocrineTherapy
Other,deep-CNN
Herceptin,neoadjuvantChemotherapyWithHerceptin
Quantification,successfulQuantificationOfCa15-3InSerumSamplesFromCancerPatients
Other,betterOutcomes
Formed,alsoShaped
Other,annualMammographyAssociatedWithEchography
Survival,progression-freeSurvival
Other,mostCommonNeoplasms
Other,95PercecntConfidenceIntervals
Other,electiveCholecystectomyForSymptomaticCholelithiasis
Spread,progressionOfTumorInvasionInBreastCarcinoma
Other,one-waySensitivityAnalyses
Other,clinicalSettingOfPreviouslyVagueDiagnosisInImaging
Discovery,areaOfResidence
Testing,analysis
Contribution,bestChancesOfCure
Restoration,conflictBetweenCareOfMother
Interference,assessmentOfImpactOfAdvancesInDiagnosisOfPatientsWithBreastCancer
Spread,cellInvasion
Other,shouldCo-managed
Other,life-threatening
Proliferation,proliferation
Other,observed
Other,iraqiWomenWhencomparedToWesternWorld
Hazard,non-standardLessPromptTreatmentsIrrespectiveOfComorbiditiesWithIncreasedRiskOfMortality/relapse
FFDM,FFDM
Distinct,distinct
Positivity,99PercecntAccuracyInTermsOfClassification
Other,suspected
Susceptibility,pb-ctMode
Purpose,role
CNN,inception-v3Cnn
Levels,levels
Other,tests
Other,bone-modulatingAgents
Finding,automaticIntraoperativeIdentificationOfBreastCancerMargins
Distinct,diseaseDefinedByTumor
Other,secondary
Other,furthermoreAssociated
Kenya,breastCancerGeneticsInKenya
Symptom,evidenceForbenefits
Other,tightDoctor-patientCollaboration
Other,fusionProteinsWithHaloTag
SNVs,SNVs
Contribution,inMarch2014BroadcastedAsPart
Spread,fewerInstancesOfSpreadToLungs
Distance,date
Adulthood,medianFollow-upOf48Years
Other,approximately75PercecntOfBreastCancers
Other,hasAssociated
Evolve,ageOfTreatmentMethods
Correlation,uncouplingOfInverseCorrelationBetweenBmi
Other,staging
Adulthood,riskOfBreastCancerInAdulthood
Survival,littleSurvivalVariance
Other,importantComponent
Other,centralDenmarkRegion
Other,employed
Infrared,infraredFluorescentDye
Water,fieldOfMedicalImagesDiagnosis
Subjective,personalGoal-setting
Description,resultOfPreviousOrbitalBiopsy
Other,sulass
Other,mostFrequentlyDiagnosedCancer
Global,heterogeneousCancerInFemalePatientsWorldwide
Subgroup,generalPopulation
Interference,inWorkSynthesizedAsSystemForDeliveryOfDoxorubicinInTreatmentOfBreastCancer
Other,southernPortuguese
Other,keys
Prevention,needsInPrevention
Other,10.1
Other,amplifications
Benchmark,thereforeCentralTarget
Other,standardMethod
Other,considered
Alpha,30TBreastMagneticResonanceImagingExaminations
Conflict,evidencedByIncreaseInContrastAfterInjection
Global,womenInWorld
Image,energyImage
Focused,multivariateModelsAdjustedForIncome
Other,couldConsidered
Other,therapy
Other,responsible
Other,noted
Reduced,decreasedGrowth
Other,cancerDiagnosis
Nonparticipation,specificallyPlacedOnInflammatoryBreastCancerWithSkinInvolvementOnCutaneousMetastasesToBreastFromBreastCancer
Utilized,hasUsed
Situations,isReplacedWithRadiotherapyInSituations
Exposure,limitedPerformanceForWomenWithDenseBreasts
Disturbances,sleepDisturbances
Other,patients'Self-monitoring
Symptom,effect
Other,contexts
Image,enhancementOfImage
Distinct,willDifferentRegardingSubtypeAtDiagnosis
Restoration,mayGoodChoiceForUnilateralPtmc
Race/color,associationBetweenRace/colorInWomenWithBreastCancer
HER2-positive,confirmedUnilateralHer2-positiveBreastCancer
Survival,synchrotronRadiation
Cohort,young
Other,neonatal
Necessity,mustAddressedDuringCancerGeneticCounselingConsultations
Spread,lymphaticInvasion
Restoration,developmentOfPolicies
Other,following
Food,ourExperience
Number,cssBenefit
Overexpressing,her2Overexpressing
Other,down-regulated
Caregiver,typicalWoman'sDisease
Purpose,willTested
Other,noninvasive
Restoration,maintenanceOfErCancerStemCells
Other,consistent
Other,oncogenesEsr1
Susceptibility,positiveChangesInTheirHealthBehaviours
Testing,medianFollow-upOf9·
Other,properImaging
Other,advancesInBreastCancerDiagnosis
Ecchymosis,expressionOfCxcChemokineReceptor-4
Other,773Percecnt
Fertility,g1/s-phaseCellCycleArrest
Other,represented
Filter,probe
Number,foundInPcosCohortThanInComparisonCohort
Other,old
Other,0.00001
Hypomethylated,oftenHypomethylated
Other,tackled
Other,profile
Global,worldwideHighestAge-standardizedBreastCancerIncidence
Binding,mir-193b-3pBindingTo3UntranslatedRegionOfMorc4
Other,4Domains
Spread,tumourSpread
Restoration,developmentOfBrainCancers
Values,seValues
Utilized,alsoUsed
Other,prohibitivelyExpensive
Hybrid,neuralNetworkClassifier
Required,thereforeRequired
Other,thusMeaningful
Other,cruciferousVegetables
Restoration,cancerCareSystems
Other,recommended
Other,challengingProblem
Contribution,lossOf020Quality-adjustedLifeYears
Estimates,estimates
Hazard,increasedRisk
Users,non-nsaidUsers
Other,product
Relative,relativeThose
Water,fieldOfBreastCancerDetection
93,93Percecnt
Number,automatedAnalysisOfClinicallyRelevantHistopathologicFeature
Will,releaseFromSerumStarvationInMcf-7Cells
Care,healthcareUtilization
Other,182Percecnt
Other,couldDetectedByMammographyBySelf-detection
Other,5-khzFrequencies
Danger,associationBetweenNsaidsExposureInFemalePatientsWithAd
Other,operablePatients
Description,molecularDiagnosisMethodMake
Other,kaplan-meierCurves
Participants,participantsWithBreastCancer
Subtypes,breastCancerMolecularSubtypes
Other,moreRecommended
Other,pre-diagnosticObesity
Other,westernBlot
MSOT,MSOT
Other,metastasisFromLobularBreastCarcinoma
16,detectedByImmunohistochemistryInApproximately70PercecntOfInvasiveBreastCancers
Focus,study
Other,pool
Spread,invasion
16,5Of10Patients
Other,importantForDiagnosis
Other,awareness
Description,randomEffectsModel
Restoration,oneExtraVisit
Other,retrospective
Subtype,triple-negativeSubtypeMda-mb-231Cells
Other,haveReported
Other,outcomes
Elusive,howeverElusive
Other,algorithm
Other,generallyReserved
Radiotherapy,chemotherapy
Debated,oftenDebated
Other,tumorNeoangiogenesisSimilarToBreastMagneticResonanceImaging
RRM2,RRM2
Other,variousRadiologicalChangesLeadingToDiagnosticChallenges
Other,linked
Other,made
Actual,moreEffectiveTreatmentOfLungCancers
Adulthood,2-3Years
Other,haveReportedInOnly003-06PercecntOfBreastCancers
Survival,survivalVariance
Alpha,m
16,about30Percecnt
Focus,haveReportedForFirstTimeInCaninesInStudy
16,50PercecntRelapsedTissues
Susceptibility,health
Scalable,scalable
Late-stage,risksOfLate-stageDiagnosis
Other,typicalHormone-dependentTumor
Other,major
Purpose,criticalRole
Other,statisticallyCorrelated
RL,RL
Cell,breastTumorProgressionIncludingTumorCellGrowth
Other,nano-biosensor
Matthews,matthewsCorrelationCoefficientOf8038Percecnt
Conflict,atEndOfFollow-upClassifiedRegardingTheirAdherenceToRecommendationsForCancerPrevention
Other,414Percecnt
Other,histologicGradeInBreastCancer
Entry,variousOtherCancerInHumanBody
Other,groups
Other,NLR
Other,cancer-relatedDeathsAmongWomen
Other,feasible
Strategy,antibody-basedStrategy
Necessity,mayNecessary
Other,diagnosisOfGallbladderMetastasis
Actual,realNeedOfSurgicalTreatment
Apoptosis,apoptosis
Accumulation,surveillancePopulation-basedData
Food,assay
Adult,whenActiveUse
Cohort,breastCancerAged
Systematic,inCanadaOfferedInOrganizedPrograms
Other,breastCancerTissues
Other,cancerTreatment
Situations,needForNodalRadiotherapyInSpecificSituations
Other,negativeEffects
Pathologic,pathologicEvaluation
Replaced,isReplaced
Other,fitted
Other,variousArtifactsIntroducedDuringSlidePreparation
Other,malign
Other,tamoxifen-resistanceInErCancerCells
Predominant,predominant
Accumulation,mainlyEurope
Mood,excellentRegionalControl
Estrogen-alone,estrogen-aloneArmOfWhi
Benchmark,thusPotentialTherapeuticTarget
Conflict,adverseEventsExceptDegreeI-iiBleeding
Distinct,differenceBetweenDifferentBreastCancerSubtypes
Other,significantlyHigherPcrRatesThanPatientsWithLuminalTypes
Radiotherapy,evenSeveralChemotherapySessions
Purpose,use
Axis,sparseCombinationOfRiemannianDictionaryAtoms
Conflict,643PercecntWithSignificantDifferenceBetweenWhites
Considerable,significantAssociationBetweenLevelsOfNek6
Other,useful
Filter,nirProbe
Restoration,moreoverPerformedOnMcf-7CellLineInPresenceOfCs/bio-mofCarrier
Other,breastCancerSubtypesa
Entry,assessedinclusionCriteriaForEnrolment
Other,earlyStageDiagnosisOfTumors
Other,urgent
Intensity,particularEmphasisQuantifying
Weight,whole-tumorSamplingOfDiseaseBurden
Testing,breastCancerScreeningProgramme
Trastuzumab,trastuzumab
Mood,breastCancerControlEfforts
Levels,levelsOfEralphaProtein
16,shorterIntervalsBetweenD
Other,virtualRecombinedImagesFromLeImages
Subgroup,standardizedDataCollection
Benchmark,optimalTherapeuticTargetForPatientWithAdvancedBreastCancer
Other,Barshi
Description,result
Mood,breastCancerControlEffortsForIdentification
Predominant,inBelgiumMostFrequentWomen'sCancerAccountingForTo353PercecntOfCases
Focus,betterAccessToAtertiaryCancerCenter
Other,common
Other,oncogenes
Parietal,leftParietalRegion
Restoration,immunocaptureOfMarker
Other,patientsWithMeasurementErrors
Other,well-established
Scientific,criticalScientificBaseForPrecisionMedicineInBreastCancer
Other,mostCommonCancer
Distinct,preciseToolForTargetedTreatmentOfCancerIncluding
Other,inflammatoryDiseases
Other,Japan
Other,moreoverStronglyRecommended
CMIA,ca15-3ByCmia
Other,processing
Other,presented
Other,this
Sensitive,sensitive
Other,diverseBiologicalProcesses
Other,organotropic
Locoregional,associationsOfFactorsWithLocoregionalAtDiagnosis
16,greaterthanorequalto10PercecntReductionInLvef
Cell,canImportantToDiagnosis
Strategy,system
Actual,formulationOfEffectiveManagementPlanForAt-riskWomen
16,11BreastRadiologists
Other,metastaticDisease
Originally,theirOriginallyTargetedPopulationsOfBreastCancer
Other,taiwanLongitudinalHealthInsuranceDatabase2005
Care,concernForExistenceOfCancerCellsInGrafts
Other,collected
Other,furthermoreMoreLikely
Pure,pureDcisInClinicopathologicCharacteristics
Other,only44Percecnt
Intensity,unnecessaryFollow-upVisitsForWomenWithVeryLowRisks
Testing,associationBetweenPreviousCervicalCancerScreeningInBreastCancerScreening
Benchmark,therapeuticTargetForPotentialTreatment
Other,pre
Hazard,RiskProtection
Danger,consensusOnAssociationBetweenExposureToDdt
Other,57PercecntOfPatients
Other,breastCancerCells
Purpose,vitalRole
Other,theirPotentialClinicalImplicationsOnBreastCancer
16,90PercecntOfPatientsWithRecurrence
Other,fused
Other,variables
Other,5Μl
Other,intopreGroups
Other,important
Other,tissueStorageTime
Other,opportunities
Other,mean
Binding,site-specificBindingLeadingToImprovedCancerTreatmentWithMinimalRisksToNormalCells
16,patientsWithMAmongThem
Restoration,goodCorrelationBetweenErAnalysedWithCytAtDiagnosisAnalysedWithIhcInArchivedFfpeTissueFromSameTumour
Interference,preoperativeAssessment
10-year,10-yearBreastCancerSurvival
Symptom,effectOfDdtSpraysOnBreastCancerIncidenceRate
Other,oestrogenReceptorCofactors
16,11Days
Other,alsoAssessedByQrt-pcr
Benchmark,canTherapeuticTargetForNextGenerationOfSerms
European,europeanCountries
Oxidation,greaterthanorequaltoReduction
Other,including
TAMs,TAMs
Other,retrospectiveStudies
Other,denseBreasts
Other,0.520
Other,arms
Other,hasApplied
Other,unusual
Alpha,her2-positiveA
Other,inNearFutureContribute
Restoration,developmentOfLymphedema
Spouses,spouses
Other,utility
Hazard,riskForRecurrence
Other,disadvantages
Other,hasMade
Required,needed
Interference,theirBeliefsRegardingCancerCausation
Provider,independentPrognosticFactorForDfsOfEarlyStageBreastCancer
Contribution,present
Other,protective
Other,haveBackbone
Testing,autopsyStudies
Other,upregulated
CS/Bio-MOF,doxUptakeByCs/bio-mof
Other,kaplanMeierCurves
Adulthood,6084Years
Other,1984
16,120Patients
16,sexualStigmatizationOfM
Cell,canDiagnosed
Global,world
Other,417Percecnt
Other,72Months
Other,BMI
Food,kernelApproach
Fertility,cellCycleRegulators
Other,discussed
Hazard,hazardRatiosWith95PercecntConfidenceIntervals
Symptom,heavySymptomBurden
ST-2,3GroupsBasedOnTertiarySolubleSt-2Level
Other,thirdInTermsOfSpecificMortality
Other,moreInclined
Caregiver,specialType
Other,hasSuggested
Other,clinico-pathologicalFeaturesOfMetastases
Membrane,atrophiedVaginalMucosa
Resistance,shouldOvercomeBeforeClinicalApplication
Other,secretion
Nonparticipation,inConclusionStronglyAssociatedWithNonparticipationInS
Focus,firmlyPlaceWithRecentTrendsTowardDecreasedRatesOfRe-excision
Other,shouldStaged
Subtype,specificSubtype
Neoadjuvant,neoadjuvantSetting
Other,tomography
Pure,shouldProcessed
Other,queried
Other,down-regulatedInTissues
Ecchymosis,expressionOfRrm2
Output,correctionMethod
Ecchymosis,preservationOfBiomarkerExpressionInOldFfpeTumour
Other,non-ideal
Syndromes,diagnosisOfAcuteCoronarySyndromes
Finding,locoregionalDiseaseOfUnspecifiedLocation
Other,histopathologicallyProvedBreastTumors
Other,solidTumors
Intensity,value
Other,pcrThanWomenWithHr-positiveTumors
Distinct,differentStages
Care,analyzedtheOperationTime
Distinct,different
Paraneoplastic,mostLikelyParaneoplastic
Contribution,theyCanImpactOnQualityOfLifePresent
Costs,costs
Other,roles
Other,determined
Ecchymosis,patientsWithHer-2PositiveExpression
Necessity,immediateUnmetNeedInClinicalPractice
Other,breastCancerConfinedWithinMammaryDuctsSurrounded
16,womenWithG
Purpose,roleOfEstrogens
Resistance,importantApplicationProspects
Utilized,widelyUtilized
Other,pathogenic
Other,inconsistentResults
Interference,barrierFunction
Survival,survivalThanAdjuvantTherapy
Other,anticipated
Other,retrieved
Number,base
Other,howeverWidelyUnderstood
Testing,importanceOfNondestructiveTestingInDefectStudies
Other,manifold
Other,scrutinised
Ecchymosis,mir-511Expression
Other,pregnancyOutcomes
Mechanism,theirContraceptivePreferences
Other,patientsWithNeoplasticDisease
Intensity,significantlyCorrelatedWithTumorSize
Subgroup,17MillionPeople
Replaced,replaced
Danger,secondLeadingCause
Other,SpCM
Other,unknown
Other,advancedDiagnosticImaging
Obstetrician,pathologistAnnotation
DNA,dnaMethylationDifferencesBetweenTumorBreastTissue
Other,significantlyYounger
Other,anti-apoptoticEffectsOfEstradiol
Number,neonatalOfRetrospectiveCohortOfPregnantWomenWith
Caregiver,case
Considerable,reverseActiveLearningForClassificationOfHealthyBreastTissue
Other,contextOfBreastCancer
Finding,despiteTheirRarityShouldConsidered
Other,mostPowerfulTool
Basis,particular
Testing,westernBlotAnalysis
Other,analyzed
Subgroup,associationOfToll-likeReceptor6WithBreastCancerInSaudiArabianWomen
16,17Years
Water,excellentPerformanceInFieldOfMedicalImagesDiagnosis
Other,portugueseWomen
Other,mostCommonMalignantTumor
Other,related
Purpose,willTestedThroughEuropeanMyPersonalBreastScreening
Other,42
Other,stillObscure
Distinct,differentDetectionRatesInBreastCancerPatients
Distinct,obtainedFrom66FemalePatientsWithMAtDifferentTimeIntervalsForEvaluationOfCtcsByFlowCytometry
Collision,theirQuestionableImpactOnMortalityOnIncidenceOfAdvancedTumors
Other,humanErrors
Other,cross-sectionalCategories
Factors,adjustingForPotentiallyConfoundingFactors
Distinct,risk/benefitOfDifferentTreatmentModalities
Water,alcoholConsumption
Cell,canExtended
Cell,canDifficult
Other,moreAdvancedStages
Mood,acuteDangerToMother
Other,analyzedBeforeAnd
Testing,forefrontOfResearch
Restoration,healthCareSector
Focus,inPresentStudyConductedBetweenMcf-7Tamoxifen-resistantLcc2CellLines
Other,breastCancerPatients
Other,utilization
Other,included.When
Black,blackWomen
Other,breastMetastasis
Conflict,physicalActivityInPatientsWithMetastaticBreastCancer
Targeted,moreTargetedAdjuvantTreatments
Other,dissectionOfLymphNodes
Entry,bodyWeight
Other,thenPresented
Other,leastAbsoluteShrinkage
Binding,key
Other,assessments
Other,rapidBreast-cancer-tissueDiagnosis
Restoration,byDevelopmentOfHybridomaTechnologyHaveProducedInManyLaboratories
Other,breastCancerTherapy
Testing,comparison
Base,balb/cNudeMiceBearing
Global,commonMalignancyWorldwide
Other,recurrence
Basis,inConclusionDownregulatedInBreastCancer
Other,status
Other,women'sCancerAccounting
Purpose,associationBetweenPost-diagnosisLow-doseAspirinUse
16,betterUnderstandingOfRisksAssociatedWithM
Other,differentialDiagnosisInPatientsWithHistoryOfBreastSurgery
Necessity,variableMolecularMechanismsOfCarcinogenesis
Other,diet
Other,diagnosisOfBreastCancer
Other,report
Other,howeverUnderutilized
Considerable,substantialDiscordancesBetweenPrimaryTumors
Positivity,receiverOperatingCharacteristicCurves
Required,urgentlyNeeded
Other,future
Other,prognostic
Other,0.0001
Conflict,differenceBetweenClearcellPlatformsForIsolatingCtcs
Testing,patients'MedicalRecords
Other,methods
Restoration,good
Other,visualizedTheranosticsOfTumors
Cell,canUsed
Other,grafts
Other,lower
Collision,injury
Restoration,developmentOfGraphicallyTailoredScreeningTool
Amplification,signalAmplificationStrategies
Utilized,utilized
Other,potentialBiomarkerForCancerDiagnosisThanMrnaBiomarkers
Other,hasProposed
Other,breastTumorMicroenvironment
Elusive,elusive
Testing,willLeadToMortalityReductionsWithoutUsualScreeningHarms
Robust,weakToStrongReactivityToOtherCellLines
Entry,cancerCounseling
Other,neglected
HER2,her2Status
Craniotomy,excision
Other,moreRefinedStratificationThanAnatomicStageAlone
Other,nationwideRegistries
Other,unclear
Subtype-specific,subtype-specificPrognosticSignatures
Symptom,evidence
Intensity,haveValidatedByClinicalStudiesInCardiotoxicityDiagnosisInPatientsTreatedWithHighDosesOfAnthracyclinesAloneInCombinationMainlyWithTrastuzumab
SLN,positiveSln
Other,importantContributors
Restoration,development
CMIA,CMIA
Platform,platform
Other,tumor-1
Other,tumorigenesisOfCells
Other,effects
Testing,analysisInvestigate
Conflict,riskOfDeath
Other,seen
Image,correspondingHistologyImage
Other,highlyExpressed
Distinct,identificationOfDistinctiveGeneticModificationsInDifferentBreastCancerMolecularSubtypes
GTPase,gtpaseInBreastCancerCells
SLN,slnMetastasis
Other,bilateralBreastLumps
Other,breastCancerTissueMicroarrayWithAccessToReceptorAnalyses
Other,2IndependentCohorts
Purpose,roleOfPdgf-b/pdgfr-betaAxisInRareTypesOfBreastCancers
Other,popular
Other,cells
Scalable,scalableIntervention
Other,healthInitiative
Other,broadDifferentialDiagnosis
Intensity,massSpectrometry
Other,aimed
Other,radioisotope
Other,higherRisks
Predominant,mostFrequentMalignancy
Other,notablyDesigned
Mastectomies,mastectomies
Other,variousImportantFunctions
Japanese,7051UnselectedBreastCancerPatientsOfJapaneseAncestry
Susceptibility,improvement
Other,associated
Output,indicatorOfNacEffectiveness
Other,mostRelevantKind
Other,481Women
Purpose,roleOfAutoantibodiesInEarlyCancerDiagnosis
Learning,breastCancerClassification
Other,followed
Formed,formedByCo-encapsulationOfNear-infraredFluorophoreInPegylatedMicelles
Numerous,itInvolvesInManyCrucialMetabolicProcesses
Forefront,forefront
Other,comparedBetweenMetastaticSlns
Phenotype,alongsideRoutineMethodEmployedOnTexture
Entry,moreInformationAboutFurtherStratificationOfBreastCancerSubtypes
Testing,breastCancerScreening
Other,inexpensive
Other,typical
Other,EMH
Radiomics,radiomicsScore
Kazakhstan,sixteenRegionsOfKazakhstan
Therapy-related,increasedRiskOfTherapy-relatedMorbidity
Other,haveAssociated
Global,worldwide
Other,younger
Other,pH
16,21Months
Output,stat1RecruitmentToEralphaPromoterRegion
Advantage,importantCopingResource
Other,planning
Factors,similarTendencyRelatedWithPrognosticFactors
Other,suutaneousLymphaticChannelsInReal-time
Other,S+RT
Other,malignantProgressionOfBreastCancer
Nonparticipation,chemotherapyResistance
V-G,v-gCalciumChannelBindingAntibodies
Purpose,increasedRiskWithUseOfLevonorgestrelIntrauterineSystem-bothOfPotentiallyImportantFindings
Subtypes,accurateDiagnosisOfBreastCancerSubtypes
Description,survivalPrediction
Other,heterogeneousPopulationsOfCellsWithHierarchicalOrganizationDrivenByCancerStemCells
Revealed,revealed
Other,adherenceToEhtAmongBreastCancerPatients
Other,broadcasted
Other,crucial
Germline,244GermlinePathogenicVariants
Other,earlyStage
Contribution,loss
Other,problem
Other,976PercecntSensitivity
Conjugates,antibodyDrugConjugates
Mechanism,potentialMechanism
Adult,physicallyActive
Considerable,twoLargeBreastCancerDatabases
Other,training
Signature,interval
Robust,robust
Signalling,eralphaSignalling
Other,enrolled
PCOS,pcosGroups
Restoration,betterOutcomeWithGoodNegativePredictiveValue
Hazard,peakInRecurrenceRisk
Hybrid,individualRiskOfRecurrence
Distinct,clearEvidenceForbenefitsOfTanUsageInBreastCancerClassification
Symptom,firstSymptom
Other,clinicalVisits
Other,moreoverRemarkablyIncreased
Focus,inStudyDevelopedForHighlyEfficientIsolationOfCtcsFromBreastCancerPatients
Subset,meanwhileBetterThanInCapecitabineGroup
Hybrid,geneticMutation
Kazakhstan,Kazakhstan
Testing,follow-upSchemes
Other,oedema
Evolve,duringAgeAssociatedWithIncreaseOf8MoreFemaleBreastCancerCasesPer100000DuringAge50-54
HER2,foundBetweenMolecularSubtypesWithHer2
Survivors,quality-of-lifeFactorsForSurvivorsIncludingSexualDysfunction
Other,overnight
Other,twoCases
Number,increasingNumber
Pathologically,pathologicallyTumor-freeNodes
Adulthood,prospectivelyFollowedFor3YearsSinceDiagnosis
Other,positivelyAssociated
Other,minimalRisksToNormalCells
Testing,screening
Cohort,youngMexicanWomen
Testing,analysisOfLncrnaExpressionProfiles
Platform,areaUnderReceiverOperatingCharacteristicCurve
Conflict,conflict
Prevention,prevention
Other,benign
Other,previousStudies
Conflict,leadingCauseOfDeathAmongGynecologicNeoplasias
GTPase,GTPase
Other,closelyAssociated
Other,life
Other,population-basedStudies
Other,biomarkers
Nonparticipation,clinicalFeasibilityOfCtcIsolation
Other,hypothesis
Amplification,inAdditionFurtherConfirmedInEarlyStage
Survival,threeOverallSurvival
Focus,axillaryLymphNodeOfBreastCancerPatients
Clinical-pathological,empiricalTreatmentsBasedOnClinical-pathologicalCharacteristicsToUseOfTargetedApproaches
Subset,sameRangeAsCasesWithoutWavelength-dependentMeasurementErrors
Distance,firstDataOnPre-diagnosisConcentrationsOfSrankl
Other,analysed
Purpose,crucialRole
Description,fbxo22-dependentManner
Cohort,prognosesOfYoungMenWithBreastCancer
Genes,genes
Other,pairedTumor
Contribution,5-yearResultsOfPhase3Isg23-01Trial
Discovery,finding
Other,included
Phosphorylation,phosphorylation
Adulthood,twoYears
Other,englishLiterature
Other,perturbation
Other,whereDeveloped
BRCA1/2,pathogenicVariantsInBrca1/2
Other,conducted
PFS,significantlyProlongedMedianPfs
Distance,firstTimeIn1984
Restoration,at25HPost-injectionGreaterInTumorBedThanInKidneyRespectively
Other,standardMethodForEvaluationOfProposedPrognosticTumourMarkers
Other,investigated
Intensity,overallLowOfSixCirculatingMirnas
Filter,intravenousAdministrationOfOsteopontin-750Probe
Other,significantlyAssociated
Other,erCscs
Other,whereFacilitatedBySurfaceModificationOfNps
Ecchymosis,mrnaExpressionLevelOfPcdh10
Conflict,issuesOfExistingContrastAgents
Estrogen-alone,preventionOfDiagnosedBreastCancerInEstrogen-aloneArmOfWhi
Caregiver,descriptive-analyticCross-sectionalType160FemalePatientsWasselected
Quantification,feasibleInProperlySelectedCasesWithAsymptomaticNeuromasAfterAccurateTissueSampling
Other,chapter
Other,CTCs
Other,tissueMicroarray
Obstetrician,shouldCo-managedByCardiologist
Other,determine
Mood,variablesPredictiveOfNippleAreolaComplexInvolvementInPatients
Bayes,reportOnPerformanceOfBayesClassifiersLikeTreeAugmentedNaiveBayes
Other,earlyDiagnosis
Evolve,threeYearsBeforeAge64Years
Benchmark,reducedBaselineLvef
Distinct,timingOfChemotherapyForBreastCancersWithDifferentMolecularBackgrounds
Odds,noticeableDrugLoadingCapacity
Other,missed
V-G,n-typeVoltage-gatedV-gCalciumChannelBindingAntibodies
Distance,interimStageInProgressionFromDcisToInvasiveBreastCancer
Considerable,frequentLargeSingleGiantCellsWithNucleiLocatedPredominantlyWithinSupsularSinuses
Description,model
Other,clarify
Interference,disposition
Hazard,shouldPerformedInAtRisk
Water,essential
Other,PI3K/AKT/mTOR
Other,independentPrognosticPredictor
Odds,average
Other,preclinicalModels
Other,lungCancerInHuman
Other,significantlyUp-regulated
Other,q12X
Other,breastTumorProgression
Other,illiterate
Other,majorCscMarkersDescribedInInvasiveBreastCancer
Other,insufficient
STs,stsOfDeath/relapse
Understudied,understudied
Other,643Percecnt
Other,fabricated
Chosen,veryRareClinicalEntityWithOnlyFewCasesHavingReportedToDate
Alpha,1H
Other,knowledge
Hazard,riskFactorsOfLvi
Entry,information
Other,disease
Other,845Percecnt
Other,performedFromInceptionToJanuary312018
Sites,sites
Other,applied
Technique,advantageOfHigh-throughputLuminexTechnique
Restoration,markerBands
Accumulation,data
Other,only35Cases
Other,infiltrativeLesion
Other,alreadyWell-established
Other,identified
Vivo,evaluatedInVivo
Other,chronic
Output,paper
Other,westernizedCountries
Conflict,deathInWomenWorldwide
Restoration,developmentOfBreastCancer
Estimates,long-termEstimates
Finding,growth
Conflict,anti-tumorActivity
Proliferation,secondaryConfirmationOfSignalAccumulationUsingNearInfraredFluorescentImaging
Other,featuresFromImages
Distinct,ourPreviousWorkRegardingToPropertiesOfPluronicsWithDifferentPhotosensitizerForPhotodynamicTherapy
Susceptibility,healthBehaviours
Mood,activatedComplex
Race/color,forRace/colorVariableEstimatedWithAdjustmentForStatus
Odds,averageOf425±496Ctcs/2Ml
Purpose,willUsed
Weight,tumorBurden
Alpha,initialPresentationOfInvasiveBreastCancer
Other,mistakenDiagnosisOfMalignancy
Other,decades
Issues,issues
Other,distributions
Osteopontin,selectiveAccumulationOfFluorescentOsteopontinInVitroAndInVivo
Adult,memorialSloanKettering-integratedMutationProfilingOfActionableCancerTargets
Evolve,youngAge
Other,markedlyUp-regulated
Focus,inPresentStudyPerformedFor9Features
Other,resistant
Other,show
Other,patientsWithBreastCancer
Percent,mortalityRate
Other,inverselyCorrelated
Other,tumor-bearingMiceOfMcf-7BreastCancerCells
Accumulation,consistentMass-spectralData
16,knowledgeOfM
Other,MCC
Discovery,incidentalFinding
DDTs,expectedInverseCorrelationOfSerumDdtsWithBmi
Hazard,riskStratification
Other,comparedToThoseWithPregestationalBreastCancer
Necessity,need
Restoration,developmentOfNewDrugs
Lymphedema,unilateralBreastCancer-relatedLymphedema
Caregiver,type160Patients
Sensitive,alive
Other,onEsophagogastroduodenoscopyIdentifiedInAntrum
Distinct,threeDifferentUsMachines
Other,cancerMolecularDiagnosis
Other,whenSuspected
Other,subsequentlyAssessed
Benchmark,impairedBaselineCardiacFunctionExperience
Other,management
MiR-34s,anti-oncogenicRegulationOfMir-34s
Collision,impact
Other,treated
Conflict,followedFromDateOfFirstDiagnosisOfAdToEndOf2013
Purpose,protectiveRoleOfRs5743810
Interference,pre-operativeAssessment
Evolve,youngerAge
Treatments,treatments
Other,drawbacks
Germline,244GermlineVariants
Hazard,earlyBiomarkersOfBreastCancerRisk
Discovery,detection
Other,urgentClinicalProblem
Other,0.02
Bromide,reference
Other,lessVisits
Other,brca-associatedCancers
Entry,itsHistologicAppearance
T2,T2
Other,Fbxo22
Restoration,closedLoopStructure
Adulthood,years
CNVs,CNVs
Subtypes,otherSubtypesOfBreastCancer
Other,couldDetected
Benchmark,reducedBaselineCardiacFunction
Other,thereforeCriticalSignificance
Other,prognosticSignificanceOfNlrInEarlyStage
Adulthood,48Years
Survivors,youngerBreastCancerSurvivors
Other,poorerPrognosisInWomenWithBreastCancer
Other,876Percecnt
Other,bt549Cells
Care,attention
Other,WES
Other,greatPotentialInDiagnosisTherapyOfCancers
Susceptibility,theirHealthBehaviours
Testing,thematicAnalysis
Testing,PM
Description,challenge
Alpha,moreComorbiditiesThanSPatients
Heterogeneity,heterogeneity
Discovery,likelihoodOfDetectionOfMicrometastases
Other,haveDescribed
Radiotherapy,neoadjuvantChemotherapy
Amplification,positiveRegulatoryFeedbackLoopForFxyd3Amplification
Other,
Symptom,effectOfBaicalinInBreastCancer
Other,howeverHaveClarified
Conflict,cellCycleArrestFollowedByMassiveCellDeath
Phosphorylation,phosphorylationOfAkt
Restoration,ourFacility
16,subsequentMalignanciesForLung/bronchusCancerWith13PercecntSurvivorsSufferedFromSubsequentMalignancies
Township,country
Other,prognosis
Radiotherapy,systemicChemotherapy
Subset,ligand-bindingDomainAllInBreastCancerSamplesFromPatientsPreviouslyTreatedWithEndocrineTherapy
Other,x-rayMammography
European,mostEuropeanCountries
Mood,dryness
16,12EventsAmong121Patients
Positivity,betterDiagnosticAccuracyThanFfdm
Reduced,diminishedOncospheroid-formingCapacityOfBreastCancerCells
Other,aspects
Other,access
16,M
Testing,standardBiomarkerTestingByImmunohistochemistry
Other,breastCancerMcf-7
Interference,haveStudiedInTermsOfCrosstalkBetweenEstrogenReceptorAlpha
Other,dependent
Entry,body
Other,insights
Isolation,univariableLogisticRegressionModels
Testing,medicalHistory
Other,investigatedOnly
Other,resources
Benchmark,target
Subset,baGroup
Cohort,poorPrognosis
Parameters,intravoxelIncoherentMotionParameters
Other,cancerCells
Adult,mostCommonAdultCancersInKenya
VAP-1,vap-1Staining
Interval,axillaryClearance
Arabian,saudiArabianWomen
Other,Chi
Limitations,variousLimitationsIncludingToxicity
Other,DPV
Resistance,choiceOfChemotherapyInBrca-associatedCancers
Other,procedure
Food,ourExperienceOfHigh-doseRadiotherapy
Toxicity,minimumToxicityToNormalCells
Other,hormoneReceptor-positiveTumors
Collision,potentialImpact
Other,stageIi
Decrease,increase
Other,method
Focus,third-lineTreatmentForAdvancedTriple-negativeBreastCancerthisRetrospectiveStudy
Symptom,novelStrategiesForDiagnosisOfBreastCancerWithHyperglycemia
Subtyped,subtyped
Other,accomplished
Considerable,partialPathologicalResponseWithLargeAreasOfTumourRegression
Nonparticipation,resistance
Conflict,contrast
Will,releaseProfile
Other,bevacizumab-relatedCardiotoxicity
Other,differentiation
16,90Percecnt
Other,breastCancerGrading
Factors,factorsRelatedToPresenceOfMetastaticDiseaseAtDiagnosis
Other,opticalCoherenceTomographyImages
Other,breastCancerModels
Other,developed
Isolation,regression
16,13
Other,nature
Predominant,mostPrevalentMalignancyDiagnosedInPregnancy
Technique,noninvasiveImagingTechniqueForBreastCancerDiagnosis
Restoration,goodQualityEvidence
Interference,backgroundParenchymalEnhancement
ER-positive/human,er-positive/humanEpidermalGrowthFactorReceptorType2-negativeBreastCancers
Cell,canOnlyDiagnosedOnPresentationOfSymptoms
Distinct,defined
Other,significantlyCorrelated
Subgroup,associationOfPcdh10Methylation
Other,estrogen-receptorAmongOtherMarkers
Other,clinicians
Other,indicative
Other,inclined
Other,metastasectomy
Other,matched
Discovery,microfluidicsBiomarkerDetection
Other,decreasesInMortalityRates
Conflict,activity
Filter,novelNear-infraredNirFluorescentProbe
Distance,totalHemoglobinConcentration
OS,betterOs
Other,pregnancy
Other,mortalityRates
Considerable,large
Other,505PercecntOfAnalyzedCases
Focus,sentinelNodeBiopsy
Restoration,withDevelopmentOfHigh-throughputSequencingHaveDiscoveredInTumorousTissues
Discovery,detectionOfCancer
Other,0.029
Symptom,symptom
Other,dcisWithMicroinvasion
Necessity,needForAnalysisOfMetastaticTissuesAtRecurrence
Considerable,significantAssociationBetweenRs5743810AllelicFrequency
Description,asResultAreUsed
Danger,cause
Testing,treatingMedicalTeam
Other,medications
Factors,incidenceFactors
Personalized,evenMorePersonalizedFollow-upSchedules
RON,ronReceptorTyrosineKinase
Consensus,consensus
Targeted,elusiveToTargetedTherapies-theTriple-negativeBreastCancer
Other,childbearingReasonsIncluding
Linear,linearRegression
Other,known
Cohort,peripheralBlood
Conflict,associationsOfPhysicalActivityInGlobalHealthInBreastCancerSurvivors
Other,tendency
Other,features
Restoration,Development
Other,that
Other,obtainedFromPatientsWithBreastCancer
Necessity,mustAddressed
Other,screened
Exposure,itsDiagnosticPerformance
Other,252Percecnt
Sites,otherSites
Other,earlyBreastCancer
Cell,canStartedAtVeryEarlyStage
STs,STs
Cell,canConsidered
Other,timeInMostCountries
Radiotherapy,practicalImplicationsOfOngoingChemotherapy
93,forThoseWithNormalLvef93Percecnt
Conjugate,clinicalBreastExaminationCoupledAsPrimaryTool
Craniotomy,incompleteExcisionOfMalignantTissues
Herceptin,Herceptin
Focus,retrospectiveObservationalStudyOf264Her2-positiveAdvancedBreastCancer
Description,questionnaireBasedOnAnderson'SdelayModel
Sites,sixGlycosylationSites
Purpose,discrete-timePartiallyObservableMarkovDecisionProcess
Other,promoterMethylationInCertainTypesOfHumanTumors
Benchmark,promisingTherapeuticTargetForBreastCancer
Caregiver,practitionerDecisionmaking
RL,appliedTo70PatientsWithUnilateralRl
Necessity,necessity
Interference,withBetterDrugDeliveryPotentialOfNon-sphericalShapesHaveRecentlyInvestigated
Other,0.001
Other,womenWithBreastCancer
Other,postmenopausalwomen
Other,sensitivityOf786PercecntRespectively
Entry,initiationOfBreastMalignancy
Subsequent,subsequentPrimaries
Other,painless
Conflict,collisionTumorWithBreastCancerMetastasis
Restoration,panelOfMonoclonalAntibodiesAgainstNewlyEstablishedCellLine
Debated,debated
Other,significanceOfTime-trends
Testing,henceMajorResearchGoal
16,treatedWithIntraperitonealInjectionFor30Days
Signature,diagnosisOfResponseToTreatment
Other,thusCritical
Other,positivelyCorrelated
Proliferation,proliferationOfMcf-7Cells
Other,diagnosed
Hazard,cardiotoxicRisk
Other,regulationOfNras
Water,course
Adult,netherlandsCancerRegistryOf37230PatientsWithEarlyBreastCancer
Distinct,successOfSymmetricPositiveDefiniteMatrices
16,G
Distinct,differentContrastAgent
Other,vital
Other,1722Comments
Survival,survival
Other,completionOfReproductivePlans
Other,expressed
Specimen,only1ulOfSerumSample
Other,normalDucts
Other,fluorescenceImaging
Other,evaluation
Intensity,lowCountries
Other,thereforeAdministered
Other,thanDcis
Understudied,understudiedPattern
Other,estrogenReceptor
Symptom,oftenWellScrutinisedByPathologistsForEvidenceOfMetastaticCarcinomaAsImportantPrognosticParameterInStandardSetting
Cohort,public
Other,ranging
Discovery,immunohistochemicalDetectionOfErPerformedInRoutineClinicalPractice
Intensity,outcomeInEr-positive/humanEpidermalGrowthFactorReceptorType2-negativeBreastCancersWithHighHazardRatiosIndependentlyOfOtherMarkers
Entry,probablyTranscriptionalActivation
Other,4Categories
Considerable,significantCausativeGenes
Other,doublingTimeOfOccult
Fertility,variousCellularProcessesCellCycleRegulation
Survival,radiation
Personal,theirOwnParticularity
16,13Percecnt
Hazard,theirRisk
Focus,descriptiveStudy
Other,pleuralDiseaseProgression
Biopsy,biopsy
Adverse,similarSeriousAdverseEvents
Other,protected
Other,cscMarkers
Other,microscopicImages
Other,assessed
Expert,bulkyHighlyTechnical
Subgroup,patternsOfAssociationResults
Hazard,outcome
Mood,additionalLocalControl
Other,consequencesForSurvival/relapse
MiR-193b-3p,mir-193b-3pIdentifiedAsRegulator
Other,proteinS-100
Other,standard
Other,nextMade
FFDM,89FfdmCases
Originally,theirAbilityOfPrognosisPredictionInTheirOriginallyTargetedPopulationsOfBreastCancer
Hazard,adjustedHazardRatio
Actual,potentialOfAionAsEffectiveMultimodalContrastAgentForBreastCancerDiagnosis
Other,125DogSeraSamplesIncluding75MammaryTumourSera
Purpose,newDesignDouble-layerCapacitors
Other,based
Focus,retrospectiveStudyOfWomenTreatedWithTrastuzumabForHumanEpidermalGrowthFactorReceptor2BreastCancerAtMayoClinicBetweenJanuary12000
Subgroup,association
Pleurodesis,pleurodesis
Other,couldDetectedEarly
Utilized,haveUsed
Number,alarm
Other,moreLikely
Other,similar
Interference,tripleAssessmentFollowed
Specimen,sample
Restoration,widelyAcceptedAsStandardOfCareFollowingBreastConservation
Entry,humanBody
Utilized,hasWidelyUsed
Anastrozole,adjuvantAnastrozole
Susceptibility,generalHealth
Limitations,limitations
MiRNA-21,successfulFunctionalizationOfNanocompositeOfSpecificSequenceOfAminatedComplementaryOligonucleotideOfMirna-21
Other,patientsByTrastuzumab-pretreatment
Other,4
Focus,inStudyDevelopedByCell-selex
Other,SVM
16,510YearsAfterSurgery
Other,fourTypesOfBreastCancer
Provider,riskFactor
Positivity,accuracy
Intensity,mass
Other,historyOfBreast-conservingSurgery
Craniotomy,keysToSuccessfulChestWallResectionForLocallyRecurrentBreastCancerAfterMastectomy
Other,news
Testing,oneScreeningProgramme
Actual,highlyEffective
Provider,protectiveFactor
Other,secondSurgery
Food,embeddingIntoReproducingKernelHilbertSpace
Yoga,intralaboratoryValidationSet
Young,performedInFemaleParticipantsWithBreastCancerFromJune2015ToDecember2017
Other,expressedSeparately
Distance,firstTime
Restoration,mustIndividualizedWithEmphasisOnOptimalCareOfMother
Distance,firstFiveFacebookOpenBreastCancerGroupsInYear2016
Caregiver,therapeuticAdvantagesParticularlyInCaseOfPremenopausalBreastCancers
Other,humanBiofluid
Interference,delivery
Hereditary,inheritableBi-objectiveCombinatorialGeneticAlgorithm
Other,accessToEarlyDiagnosis
Other,trend
Utilized,areUsed
Immunohistochemistry,hasPutOnIntrinsicSubtypingBasedInPresenceOfClassicalImmunohistochemistry
Membrane,panel
Subjective,personalGoals
Other,possibility
Other,localTherapyOfBreastCancer
Focused,hasFocused
Other,malignant
Correlation,correlation
Predominant,mostFrequentCancerInWomenTreatedWithHormonalTherapy
Benchmark,targetRelationshipBetweenDscam-as1
Subset,totalGroup
Other,patientsOnAromataseInhibitors
Restoration,inStudyFusedWithMouseMyelomaCellLineSp2/0InPresence
Ecchymosis,nf-krab-inducedIncreasedExpressionOfCcnd1
Other,D538G
Restoration,postmenopausalWomenWithDevelopmentOfBreastCancer
Testing,concentrationsOfVegf-aInComparisonToCa15-3InBreastCancer
Kenya,Kenya
Other,51Days
Evolve,possibleCorrelationsWithClinicalStatusIncludingAge
Obstetrician,generalRadiologistAboutSystemicDiseases
Other,agents
Canines,canines
Other,China
Other,findings
Other,harmfulorHarmlessTissues
Restoration,goodDiagnosticPerformance
Formed,formed
Areola,sideEffects
Other,treatment
Other,urgentlyDeveloped
Cohort,youngWomen
Adult,active
Cohort,poorAdhesion
Other,painlessLumpInBreastAccountingFor688PercecntOfPatients
16,C
Other,2012AtBreastClinicOfPortugueseInstituteOfOncologyInPorto
Other,992PercecntOfCases
Other,context
Other,vitalRoles
Cohort,mostCommonCancerOfAdolescentsAgedAccountingFor56PercecntOfInvasiveBreastCancerInWomen
Other,therebyFrequentlyNeglected
Other,driven
Other,.014
Other,found
Other,hasReported
Prior,mayUsedForTumourShrinkagePriorToSurgery
DOX,cytotoxicityOfFreeDoxMolecules
Apoptosis,impededApoptosis
Other,AUC
Purpose,aspirinUse
Number,inConclusionPathogenicFeatureInPrimarySamples
Platform,commonPlatformForStakeholdersIncludingPolicymakers
Other,treat
Other,complementaryApproaches
Resistance,potentialApplicationForDiagnosisOfCancerInFuture
Other,localExcision/lumpectomy
Ecchymosis,prognosticMeritOfNek6ExpressionInBreastCancer
Other,earlyBreastCancerSurgery
Other,68Percecnt
Positivity,diagnosisAccuracy
Other,referral
Other,documented
Chosen,throughOptimizationTestsChosenAsOptimalConditions
Subgroup,associationBetweenTumorUptakeInInvasiveDuctalCarcinoma
Provider,tumorNecrosisFactor
Testing,relatedResearchDataOfDiagnosisOfInoperableLocallyAdvancedBreastCancer
Other,hasRecentlyProposedAsCrucialRegulatorOfTriple-negativeBreastCancer
Other,understand
Caregiver,unusualCaseOfPtosis
Sites,averageOfFiveInvolvedSites
PCDH10,pcdh10GenePromoterMethylationIdentifiedInDuctalCarcinoma
Other,invasiveCarcinomaBreast
Other,obscure
Subset,highestSeInTotalGroup
Endocrine-resistant,potentialTreatmentStrategyForEndocrine-resistantBreastCancers
Sensitive,thenClassifiedBySupportVectorMachines
Other,neutralEffects
Robust,richSpectralFeaturesOfPhenyboronicAcid-basedNanoprobe
Other,safety
Other,uncover
Other,inHumanBreastCancerHasReported
Ecchymosis,expressionProfileOfNek6In133BreastCancerSpecimens
Other,inPrimaryBreastCancerTumorsExpressedDuringNeoplasticTransformation
Other,qualitativeApproach
Will,understanding
Other,connected
Other,patientsWithHistoryOfBreastSurgery
Other,kind
Other,receivedWithoutSurfaceModification
Other,shouldPerformed
Long-term,inLongTermHasFound
Pathologic,dependentOnRigorousPathologicEvaluationOnAdministrationOfTreatmentDictatedByTumorBiology
Testing,testingDatasetsCollectedFrom48Patients
Intensity,highAmountOfDox
Other,2=
Entry,heterogeneousDiseaseInItsHistologicAppearance
Other,involved
Conflict,dealingWithEndocrineResistanceInPatientsWithBreastCancer
PFS,PFS
Evolve,inTotalDiagnosedUnderAgeOf50
Other,childHealth
Intensity,massInPosteriorFossaOfBrain
Other,events
Other,pcrResults
Other,misdiagnosis
Focus,place
MABA,conventionalBafifty-fivePatientsUndergoingViaMabaForPtmc
Conflict,contrastAfterInjection
Other,hasInconsistent
Other,specificCircumstances
Other,cases
Other,patientsWithMetastaticBreastCancer
Sleep,fastDayBefore
Goal-setting,goal-setting
Other,analyzedRetrospectively
Other,logisticregressions
Other,us
Exposure,performance
Purpose,facilitatingRole
Cohort,blood
Other,multipleBiological
Caregiver,type
Accumulation,cnvData
Other,er-positiveBreastCancer
Focus,ourStudy
Benchmark,rationaleForTamsAsTherapeuticTargetInBreastCancer
Fertility,importanceOfProactivelyAddressingFertility
Decrease,harmToHealthAmongRuralWomenWithIncrementalCost-effectivenessRatio
Evolve,womenOfReproductiveAge
Caregiver,sufferingFromWoman'sDisease
Other,estimated
Coefficient,correlationCoefficientOnMetabricTrainingSet
Other,alarmingLevelGlobally
Other,preclinicalPhase
Other,independentlyAssociated
Cox,coxProportionalHazardModel
LVEF,negativelyCorrelatedWithLvef
Other,timeOfTheirAppointmentwithDoctor
Ecchymosis,geneExpressionUpregulationInBreastCancer
Caregiver,73-yearOldWomanPresentingWithLeftBreastLumpClinicallyIndeterminate
Other,characterized
Nonparticipation,endocrineTherapyResistance
Other,importance
Other,changes
Subset,thatInMabaGroup
Purpose,normalCardiacFunction
Greaterfor,howeverGreaterforPatientsTreatedInAlmatyCity
Other,thoseWithHr-positiveTumors
Other,postoperativeComplications
Mood,veryComplexDisease
MiR-511,thatOfMir-511
Subset,group2
Other,howeverMuchLower
Other,veryHeterogeneousDisease
Other,radiologicalSignsOfMalignancy
Other,67BreastCancerSamplesFrom66Patients
Other,modified
Entry,stableBodyWeight
1-2,isSentinelLymphNodesMetastasesTo1-2Nodes
Distinct,differentHistologicalAspects
Other,tumorEasily
Values,values
Pure,pureDcis
Other,comparedBetweenPremenopausalGroupsBetweenPcrGroups
Hereditary,hereditaryCausesOfChorea